Source:http://linkedlifedata.com/resource/pubmed/id/18375078
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-4-14
|
pubmed:abstractText |
7-Hydroxy-5-methyl-3-phenyl-6,7,8,9-tetrahydropyrido[3',2':4,5]imidazo[1,2-a]pyrimidin-5-ium chloride (PhIP-M1) is a newly identified intestinal microbial metabolite from the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Although the mutagenic potential of the endogenous N-hydroxy PhIP derivate has been reported, the risks associated with PhIP-M1 have not yet been explored. In this work, the cytotoxic and genotoxic effects originating from PhIP-M1 were assessed in the epithelial intestinal Caco-2 cell line. PhIP-M1 significantly decreased in a time- and dose-dependent manner mitochondrial dehydrogenase activity and protein synthesis, with IC50 values of, respectively, 180+/-39.4 and 173+/-20.3 microM after 24h, and 33.8+/-3.5 and 37.3+/-10.9 microM after 72 h. Apoptosis within the concentration ranges of cytotoxicity was confirmed by morphological examination, DAPI nuclear staining and annexin V staining. PhIP-M1 provoked cell cycle arrest, characterized by a significant increase in the number of nucleoids in the G2/M phase. A dose-dependent increase in DNA damage, as quantified by the alkaline comet assay, was observed after 3h in the 50-200 microM range. Because these PhIP-M1-induced genomic and cellular events may contribute to the carcinogenicity of PhIP, the potency of the colon microbiota to bioactivate PhIP must be included in future risk assessments.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2-amino-1-methyl-6-phenylimidazo(4,5...,
http://linkedlifedata.com/resource/pubmed/chemical/Carcinogens,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Mutagens,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0378-4274
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:volume |
178
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
61-9
|
pubmed:meshHeading |
pubmed-meshheading:18375078-Apoptosis,
pubmed-meshheading:18375078-Caco-2 Cells,
pubmed-meshheading:18375078-Carcinogens,
pubmed-meshheading:18375078-Cell Cycle,
pubmed-meshheading:18375078-Cell Proliferation,
pubmed-meshheading:18375078-Cell Survival,
pubmed-meshheading:18375078-Comet Assay,
pubmed-meshheading:18375078-DNA Damage,
pubmed-meshheading:18375078-Humans,
pubmed-meshheading:18375078-Imidazoles,
pubmed-meshheading:18375078-Mutagens,
pubmed-meshheading:18375078-Pyrimidines
|
pubmed:year |
2008
|
pubmed:articleTitle |
The microbial PhIP metabolite 7-hydroxy-5-methyl-3-phenyl-6,7,8,9-tetrahydropyrido[3',2':4,5]imidazo[1,2-a]pyrimidin-5-ium chloride (PhIP-M1) induces DNA damage, apoptosis and cell cycle arrest towards Caco-2 cells.
|
pubmed:affiliation |
Laboratory of Microbial Ecology and Technology, Faculty of Bioscience Engineering, Ghent University-UGent, Coupure Links 653, B-9000 Ghent, Belgium. Lynn.Vanhaecke@ugent.be
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|